Abstract:BACKGROUND:NQO1 (NAD(P)H: quinone oxidoreductase-1), located on chromosome 16q22, functions primarily to protect normal cells from oxidant stress and electrophilic attack. Recent studies have revealed that NQO1 is expressed at a high level in most human solid tumors including those of the colon, breast, pancreas, ovaries and thyroid, and it has also been detected following the induction of cell cycle progression and proliferation of melanoma cells. In this study, we aimed to investigate the clinicopathological significance of upregulated NQO1 protein expression in squamous cell carcinomas (SCCs) of the uterine cervix.METHODS:The localization of the NQO1 protein was determined in the SiHa cervical squamous cancer cell line using immunofluorescence (IF) staining, and immunohistochemical (IHC) staining performed on paraffin-embedded cervical SCC specimens from 177 patients. For comparison, 94 cervical intraepithelial neoplasia (CIN) and 25 normal cervical epithelia samples were also included. QRT-PCR was performed on RNA from fresh tissues to detect NQO1 mRNA expression levels, and HPV infection status was genotyped using oligonucleotide microarray. Disease-free survival (DFS) and 5-year overall survival (OS) rates for all cervical SCC patients were calculated using the Kaplan-Meier method, and univariate and multivariate analysis was performed using the Cox proportional hazards regression model.RESULTS:The NQO1 protein showed a mainly cytoplasmic staining pattern in cervical cancer cells, and only three cases of cervical SCC showed a nuclear staining pattern. The strongly positive rate of NQO1 protein expression was significantly higher in cervical SCCs and CINs than in normal cervical epithelia. High-level NQO1 expression was closely associated with poor differentiation, late-stage, lymph node metastasis and high-risk for HPV infection. Additionally, high-level NQO1 expression was associated with lower DFS and 5-year OS rates, particularly for patients with early-stage cervical SCCs. Furthermore, Cox analysis revealed that NQO1 expression emerged as a significant independent hazard factor for DFS rate in patients with cervical SCC.CONCLUSIONS:NQO1 overexpression might be an independent biomarker for prognostic evaluation of cervical SCCs.

Low expression of NCOA5 predicts poor prognosis in human cervical cancer and promotes proliferation, migration, and invasion of cervical cancer cell lines by regulating notch3 signaling pathway.

NCOA5 Low Expression Correlates with Survival in Esophageal Squamous Cell Carcinoma.

Association Between Expression of Nuclear Receptor Co-Activator 5 Protein and Prognosis in Postoperative Patients with Osteosarcoma

High Expression of UNC5B Enhances Tumor Proliferation, Increases Metastasis, and Worsens Prognosis in Breast Cancer.

NCOA7 Regulates Growth and Metastasis of Clear Cell Renal Cell Carcinoma via MAPK/ERK Signaling Pathway

NCOA5 promotes proliferation, migration and invasion of colorectal cancer cells via activation of PI3K/AKT pathway.

Expression of nuclear receptor co‐activator 7 protein is associated with poor prognosis of breast cancer

The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma.

Knockdown of NCOA2 Inhibits the Growth and Progression of Gastric Cancer by Affecting the Wnt Signaling Pathway-Related Protein Expression

HOXA5 Inhibits the Proliferation and Neoplasia of Cervical Cancer Cells Via Downregulating the Activity of the Wnt/β-catenin Pathway and Transactivating TP53.

CORRELATION BETWEEN THE EXPRESSION LEVEL OF NUCLEAR RECEPTOR COACTIVATOR 1 AND CLINICOPATHOLOGICAL FEATURES AND PROGNOSIS IN BLADDER CANCER

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Advances of NOTCH 1 Signaling in Cervical Cancer

HOXA5 Indicates Poor Prognosis and Suppresses Cell Proliferation by Regulating P21 Expression in Non Small Cell Lung Cancer

Low Expression of Long Noncoding XLOC_010588 Indicates a Poor Prognosis and Promotes Proliferation Through Upregulation of C-Myc in Cervical Cancer

Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK Pathway.

NQO1 Overexpression is Associated with Poor Prognosis in Squamous Cell Carcinoma of the Uterine Cervix

COL5A1 Overexpression Correlates with Poor Prognosis in Human Cervical Cancer

LINC00511 is associated with the malignant status and promotes cell proliferation and motility in cervical cancer

NCOA4: An Immunomodulation-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer

Long Non-Coding RNA GAS5 Regulates the Growth and Metastasis of Human Cervical Cancer Cells Via Induction of Apoptosis and Cell Cycle Arrest